Pharma Business review is using cookies

ContinueLearn More
Close
October 15, 2018

Alliqua BioMedical, Adynxx enter into merger deal

Alliqua BioMedical has entered into a merger agreement with Adynxx to create a clinical-stage pharmaceutical firm, which will focus on development of therapies for pain and inflammation.

Image: Alliqua BioMedical has entered into a merger agreement with Adynxx. Photo: courtesy of rawpixel / Unsplash.